JP2017533935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533935A5 JP2017533935A5 JP2017525907A JP2017525907A JP2017533935A5 JP 2017533935 A5 JP2017533935 A5 JP 2017533935A5 JP 2017525907 A JP2017525907 A JP 2017525907A JP 2017525907 A JP2017525907 A JP 2017525907A JP 2017533935 A5 JP2017533935 A5 JP 2017533935A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- cycloalkyl
- compound according
- monocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 8
- 125000002950 monocyclic group Chemical group 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 208000002193 Pain Diseases 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- -1 C 1-6 -alkyl-O— Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 230000002981 neuropathic effect Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14193182 | 2014-11-14 | ||
| EP14193182.4 | 2014-11-14 | ||
| PCT/EP2015/076439 WO2016075239A1 (en) | 2014-11-14 | 2015-11-12 | Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (sstr4) agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533935A JP2017533935A (ja) | 2017-11-16 |
| JP2017533935A5 true JP2017533935A5 (enExample) | 2018-12-27 |
| JP6590927B2 JP6590927B2 (ja) | 2019-10-16 |
Family
ID=51904764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525907A Active JP6590927B2 (ja) | 2014-11-14 | 2015-11-12 | ソマトスタチン受容体サブタイプ４（ｓｓｔｒ４）作動薬としてのアリール及びヘテロアリール縮合テトラヒドロ−１，４−オキサゼピンアミド |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10183940B2 (enExample) |
| EP (1) | EP3218371B1 (enExample) |
| JP (1) | JP6590927B2 (enExample) |
| WO (1) | WO2016075239A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR121683A1 (es) * | 2020-03-31 | 2022-06-29 | Takeda Pharmaceuticals Co | Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4 |
| TW202146403A (zh) * | 2020-05-21 | 2021-12-16 | 大陸商廣州費米子科技有限責任公司 | 含氮飽和雜環化合物及其製備方法、藥物組合物和應用 |
| CN112552303B (zh) * | 2020-12-14 | 2021-11-30 | 承德医学院 | 嘧啶酮并二氮杂卓类化合物及其盐、其制备方法及医药用途 |
| TWI860849B (zh) | 2021-09-14 | 2024-11-01 | 美商美國禮來大藥廠 | Sstr4促效劑鹽 |
| WO2025247982A1 (en) | 2024-05-29 | 2025-12-04 | Grünenthal GmbH | Piperazines which act as sstr4 modulators |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT100631B (pt) * | 1991-06-28 | 1999-06-30 | Smithkline Beecham Corp | Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem |
| JPH11209356A (ja) * | 1997-04-21 | 1999-08-03 | Takeda Chem Ind Ltd | 縮合環化合物、その製造法及び剤 |
| EP0979227B1 (en) | 1997-04-21 | 2005-11-16 | Takeda Pharmaceutical Company Limited | 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| WO2002053543A1 (en) * | 2000-12-28 | 2002-07-11 | Shionogi & Co., Ltd. | Pyridone derivative having affinity for cannabinoid 2-type receptor |
| WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| WO2008108445A1 (ja) | 2007-03-07 | 2008-09-12 | Takeda Pharmaceutical Company Limited | ベンゾオキサゼピン誘導体およびその用途 |
| PE20091339A1 (es) * | 2007-12-21 | 2009-09-26 | Glaxo Group Ltd | Derivados de oxadiazol con actividad sobre receptores s1p1 |
| WO2010007382A1 (en) * | 2008-07-18 | 2010-01-21 | Takeda Pharmaceutical Company Limited. | Benzazepine derivatives and their use as hstamine h3 antagonists |
| WO2010059922A1 (en) * | 2008-11-21 | 2010-05-27 | Ligand Pharmaceuticals Incorporated | Pyrrolidine carboxamide compounds |
| WO2012164085A1 (en) * | 2011-06-03 | 2012-12-06 | Merz Pharma Gmbh & Co. Kgaa | Glycine b antagonists |
| JP2013189395A (ja) * | 2012-03-14 | 2013-09-26 | Dainippon Sumitomo Pharma Co Ltd | ジヒドロピロロピラジノン誘導体 |
| TWI637951B (zh) * | 2013-02-15 | 2018-10-11 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺類 |
| US9371282B2 (en) | 2013-05-17 | 2016-06-21 | Centrexion Therapeutics Corporation | Somatostatin receptor subtype 4 (SSTR4) agonists |
| CN103497181B (zh) * | 2013-09-30 | 2016-03-30 | 承德医学院 | 作为糖原磷酸化酶抑制剂的苯并氮杂卓酮类化合物、其制备方法及医药用途 |
-
2015
- 2015-11-12 EP EP15793839.0A patent/EP3218371B1/en active Active
- 2015-11-12 WO PCT/EP2015/076439 patent/WO2016075239A1/en not_active Ceased
- 2015-11-12 JP JP2017525907A patent/JP6590927B2/ja active Active
- 2015-11-12 US US15/526,360 patent/US10183940B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533930A5 (enExample) | ||
| JP2016518430A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2017533935A5 (enExample) | ||
| JP2013209405A5 (enExample) | ||
| EA201600622A1 (ru) | Бициклические анелированные гетероарильные или арильные соединения и их применение в качестве ингибиторов irak4 | |
| EA201890888A1 (ru) | Новые спиро[3h-индол-3,2'-пирролидин]-2(1h)-оновые соединения и производные в качестве ингибиторов mdm2-p53 | |
| JP2016106149A5 (enExample) | ||
| EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
| JP2012504133A5 (enExample) | ||
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| JP2014511892A5 (enExample) | ||
| BR112012027743A2 (pt) | ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas | |
| JP2016513130A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| EA201491018A1 (ru) | Новые бициклические производные дигидроизохинолин-1-она | |
| JP2018521056A5 (enExample) | ||
| EA201890654A1 (ru) | Терапевтические композиции для лечения вируса иммунодефицита человека | |
| JP2011513410A5 (enExample) | ||
| JP2016528273A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2015526455A5 (enExample) | ||
| JP2018514522A5 (enExample) | ||
| RU2017103656A (ru) | Производные изоиндолинона, полезные в качестве противовирусных средств | |
| JP2016533368A5 (enExample) |